
Glimter PM 2mg/500mg/7.5mg Tablet SR
Marketer
Bluewaterresearch
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Glimter PM 2mg/500mg/7.5mg Tablet SR
Glycemic Control Tablet SR (2mg/500mg/7.5mg) is a triple-combination medication managing blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It optimizes insulin utilization, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen for Glycemic Control Tablet SR. Ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in this case, omit the missed dose and resume the usual schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals increases the risk of hypoglycemia; consistent blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Baseline kidney function tests are mandatory before initiating therapy. Limit alcohol consumption to reduce the potential for increased side effects.
Primary Ingredients of Glimter PM 2mg/500mg/7.5mg Tablet SR
There is no text provided to rephrase.
Uses of Glimter PM 2mg/500mg/7.5mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimter PM 2mg/500mg/7.5mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Glimter PM 2mg/500mg/7.5mg Extended-Release Tablets with food.
Common Side effects of Glimter PM 2mg/500mg/7.5mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimter PM 2mg/500mg/7.5mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; do not fragment, pulverize, or chew it. Consume Glimter PM 2mg/500mg/7.5mg Extended-Release tablets with food.
How Glimter PM 2mg/500mg/7.5mg Tablet SR works:
Glimter PM 2mg/500mg/7.5mg Extended-Release tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct modes of action to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimter PM 2mg/500mg/7.5mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimter PM 2mg/500mg/7.5mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimter PM tablets (2mg/500mg/7.5mg) are likely not safe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should use Glimter PM 2mg/500mg/7.5mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, Glimter PM 2mg/500mg/7.5mg SR tablets are contraindicated. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimter PM 2mg/500mg/7.5mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimter PM 2mg/500mg/7.5mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimter PM 2mg/500mg/7.5mg Tablet SR :
Should you forget to take your Glimter PM 2mg/500mg/7.5mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimter PM 2mg/500mg/7.5mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
